Amanda Nash is an Assistant Professor in the Department of Bioengineering at Rice University, where she leads a research program aimed at developing cell communication technologies to treat a range of human diseases, including cancer, autoimmune diseases, and aging. Throughout her career, Amanda has authored or co-authored numerous peer-reviewed publications and patents in the immunoengineering and drug delivery space. The Nash lab utilizes techniques in immunoengineering, molecular diagnostics and materials science to develop innovative strategies for controlled modulation of the immune system and is heavily focused on clinical translation of immunomodulatory technologies. 

Amanda earned her Ph.D. in Bioengineering from Rice University, where she worked with Omid Veish to develop implantable cytokine factories for the treatment of ovarian cancer. Following graduate school, Amanda trained as a management consultant at McKinsey and Company where she specialized in business development, portfolio strategy and operational excellence for top pharmaceutical and medtech companies.